abstract |
Modified release pharmaceutical formulations comprising microcapsules of amoxicillin, optionally immediate release amoxicillin and optionally clavulanate are of use in treating bacterial infections, in particular the empirical treatment of infections where penicillin resistant S pneumoniae may be implicated. |